The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Understanding LRRK2 Biology, 2009Functional Analysis of LRRK2
Objective/Rationale:
LRRK2 is a gene that, when not working properly, causes Parkinson’s disease. However, the function of this large gene and its involvement in the disease process is virtually... -
Understanding LRRK2 Biology, 2009Development of Biochemical Assays for LRRK1
Objective/Rationale:
Studies over the last several years have identified the protein kinase LRRK2 as a potential target for Parkinson’s disease therapeutics. While targeting kinases has been a... -
Biomarkers, 2009T-Cell Receptors Changes as a Biomarker of Parkinson's Disease
Objective/Rationale:
The diagnosis of PD is based on clinical characteristics because there are no reliable blood tests for early diagnosis or to follow the progressive course of the disease. Along... -
Rapid Response Innovation Awards, 2009Defining Genetic Factors for PD in a Conserved Population
Objective/Rationale:
The identification of genes underlying risk for Parkinson’s disease (PD) helps to further the understanding of this complex disorder, with the discovery of new genes contributing... -
Program-non-specific Funding, 2009Data Repository for Experimental Data
Objective/Rationale:
Synthesizing biomedical data into effective discoveries is greatly hampered by the way science is both reported in research articles and stored in databases. Articles do not... -
Rapid Response Innovation Awards, 2009Development of Potent Conformation-Specific Compounds Directed to Monomeric Alpha-Synuclein
Promising Outcomes of Original Grant:
The goal of our original funded grant was to use our alpha-synuclein assay to identify compounds that prevent conformational change to the fully open form of the...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.